Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

1.78
+0.01000.56%
Volume:80.58K
Turnover:143.35K
Market Cap:22.71M
PE:-1.09
High:1.87
Open:1.73
Low:1.72
Close:1.77
52wk High:4.70
52wk Low:1.11
Shares:12.76M
Float Shares:10.14M
Volume Ratio:0.60
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-7.06
PE(LYR):-1.13

Loading ...

Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 24, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 12, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 10, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 30, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 23, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 23, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Major Issues Report

Form 8-K - Current report